Browse diseases

…tions between employment quality, all-cause and cause-specific (cancer, cardiovascular and unintentional injury) mortality, by sex/gen…

…83, p=0.033).Conclusions AYA patients receiving ICI therapy for melanoma had high incidence of colitis and hepatitis and favorable survi…

…ded based on predefined criteria, including adult patients with cancer receiving paclitaxel infusions. Quality of included studies was…

…between 2014 and 2020 and were eligible for genetic testing for hereditary cancer syndromes.Primary and secondary outcome measures The primary outcome was …

…M) continues to rise, with implications on cardiovascular risk, metabolic liver disease and cancer incidence.1 Despite advances in pharmacological mana…

…ce. Clinicians are moving insights from bench to bedside across cancer, infection, autoimmunity, allergy, neurology, transplantation a…

…mortality were age (>59 years) (aHR 5.53; 95% CI 3.17 to 9.65), renal disease (aHR 2.98; 95% CI 2.27 to 3.90), HIV infection (aHR 2.82; 95% C…

… database was used to identify registrational trials supporting cancer drug approval from 2004 through 2023. Clinical trial design (es…

…Patients underwent unnecessary mastectomies or had cancer diagnoses delayed because of long running systemic failures at …

…ss North America, Europe, Africa and Australia. Half focused on cancer; others addressed malaria, autism, hypothyroidism, HIV preventi…

…use included myocarditis (n=8), arthritis (n=4), colitis (n=3), hepatitis (n=3), encephalitis (n=2), pneumonitis (n=2), myasthenia gravis…

…tors (ICI) demonstrate significant efficacy in the treatment of cancer but are commonly associated with immune related adverse events.…